Skip to main content
logo
Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
4.125
-0.035 (-0.84%)
Nov 28, 2025, 4:00 PM EST - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2021FY 2019FY 20182010 - 2017
Period Ending
Dec '24 Dec '23 Dec '21 Dec '19 Dec '18 2010 - 2017
Gene Therapeutics
1.00M
Log In
Log In
Log In
Log In
Upgrade
Gene Therapeutics Growth
-72.22%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2021FY 2019FY 20182010 - 2017
Period Ending
Dec '24 Dec '23 Dec '21 Dec '19 Dec '18 2010 - 2017
United States
1.00M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-72.22%
Log In
Log In
Log In
Log In
Upgrade